Can C-Peptide Suggest MODY After Years of Diabetes?

Yes. If you have been diagnosed with diabetes (particularly Type 1) for more than three to five years, checking your C-peptide level can still be a very useful tool for your care team. C-peptide measures how much insulin your own pancreas is still producing. While many people with Type 1 diabetes see their C-peptide levels drop to near zero over time, people with MODY (Maturity-Onset Diabetes of the Young) usually continue producing their own insulin for decades ^[1].

Finding an unexpectedly preserved C-peptide level after several years of having diabetes raises clinical suspicion and may prompt your doctor to review your original diagnosis ^[2]. However, a detectable C-peptide by itself does not diagnose MODY, nor does it rule out Type 1 diabetes—it is simply a clue that genetic testing might be appropriate ^{[3] [4]}.

Crucial Safety Warning: Never stop taking or reduce your insulin based on a C-peptide result. People with Type 1 diabetes can develop life-threatening diabetic ketoacidosis (DKA) even when some C-peptide remains. Any changes to your treatment must be directed by your diabetes care team, often only after a confirmed genetic diagnosis.

What is C-Peptide and Why Does Time Matter?

Whenever your pancreas creates insulin, it releases a byproduct called C-peptide. Because they are released in exactly equal amounts, measuring C-peptide is a highly reliable way for doctors to see how much insulin your body is making on its own, completely separate from any insulin you might inject.

Time is a key factor when interpreting this test because of how different types of diabetes progress:

• In Type 1 Diabetes: The body’s immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This causes a progressive loss of beta-cell function (the pancreas’s ability to make insulin). Usually, after 3 to 5 years, many people reach absolute insulin deficiency (an undetectable or profoundly low C-peptide level) ^{[5] [1]}. However, this is variable—some people with Type 1 diabetes, especially those diagnosed as adults, retain a small amount of insulin production for years.
• In MODY: The disease is caused by a genetic mutation, not an autoimmune attack. Because the beta cells are not actively being destroyed by the immune system, people with MODY generally continue to produce their own insulin for a very long time ^{[1] [6]}.

Context is Everything: The Rules of Testing

A C-peptide result cannot be interpreted in a vacuum. Your doctor must look at the specific conditions of your test:

• Concurrent Blood Sugar: C-peptide must be evaluated alongside your blood sugar level at the exact time the sample was drawn. If your blood sugar was low, your pancreas naturally stopped making insulin, so a low C-peptide in that moment might be completely normal ^[7].
• Kidney Function: C-peptide is cleared from the body by the kidneys. If you have impaired kidney function, C-peptide builds up in the blood and can appear artificially high.
• Test Type: Your doctor will choose between a fasting test (first thing in the morning before food), a random blood draw, or a stimulated test (like after a meal) depending on what they are looking for ^{[8] [7]}.

How C-Peptide Points to MODY

If you have been told you have Type 1 diabetes but still have unexpectedly preserved C-peptide after three or more years, it is a clinical signal that the original diagnosis could be reviewed ^[2].

Research shows that C-peptide often persists in monogenic diabetes (like MODY). In one small study, a majority of patients with a monogenic form of diabetes still had random C-peptide levels over 100 pmol/L (approx. 0.30 ng/mL) more than 15 years after their initial diagnosis ^[1]. Another illustrative case showed robust C-peptide production 6 years after a Type 1 diagnosis, eventually leading to a correct diagnosis of HNF1A-MODY ^[6].

Doctors use specific studies to help guide testing decisions. For example:

• Random C-peptide: One study found that having a random C-peptide level of ≥0.1 ng/mL (approx. 33 pmol/L) after at least 3 years of having presumed Type 1 diabetes is a useful trigger to run a genetic test ^[2].
• UCPCR (Urinary C-peptide Creatinine Ratio): This is a screening test measuring C-peptide in the urine, usually collected after a meal. Studies show a UCPCR greater than 0.2 nmol/mmol can be highly effective at distinguishing specific subtypes of MODY (like HNF1A and HNF4A) from long-standing Type 1 diabetes ^{[9] [3]}.

A Clue, Not a Diagnosis

While a preserved C-peptide level is incredibly helpful, it is important to understand its limitations:

• It is a screening tool: C-peptide helps identify who should undergo genetic testing, but only a genetic test (blood or saliva) can definitively diagnose a specific gene mutation ^{[3] [4]}.
• Not all MODY is the same: Subtypes like HNF1A-MODY and HNF4A-MODY (named after the specific gene that is mutated) often show strong C-peptide levels after a meal ^[3], but other rarer types might naturally have lower fasting C-peptide levels ^[10]. Even in MODY, the pancreas’s ability to make insulin can slowly decline over decades ^[11].
• Overlap with other types: C-peptide levels in MODY overlap heavily with Type 2 diabetes, and as mentioned, even a subset of Type 1 patients ^{[12] [1]}.
• Autoantibodies aren’t perfect: Doctors often check islet autoantibodies (immune markers present in most Type 1 diabetes cases). While having negative autoantibodies increases the suspicion of MODY, it does not guarantee it. Some people with Type 1 diabetes test negative for these antibodies ^{[3] [13]}.

Because of these nuances, your doctor will interpret your C-peptide results alongside your antibody status, family history (keeping in mind that misdiagnosed family members can obscure the true history), and the length of time you have had diabetes to decide if a genetic testing panel is the right next step ^{[3] [4]}.